首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   180774篇
  免费   11611篇
  国内免费   710篇
耳鼻咽喉   2536篇
儿科学   4932篇
妇产科学   3451篇
基础医学   23383篇
口腔科学   3589篇
临床医学   17661篇
内科学   38740篇
皮肤病学   2879篇
神经病学   18159篇
特种医学   6333篇
外国民族医学   13篇
外科学   26860篇
综合类   2326篇
现状与发展   3篇
一般理论   201篇
预防医学   13428篇
眼科学   4805篇
药学   11585篇
中国医学   205篇
肿瘤学   12006篇
  2023年   706篇
  2022年   1235篇
  2021年   2896篇
  2020年   1769篇
  2019年   2916篇
  2018年   3425篇
  2017年   2483篇
  2016年   2897篇
  2015年   3496篇
  2014年   5154篇
  2013年   7947篇
  2012年   11492篇
  2011年   12320篇
  2010年   6889篇
  2009年   6340篇
  2008年   11617篇
  2007年   12369篇
  2006年   11901篇
  2005年   12258篇
  2004年   11618篇
  2003年   11100篇
  2002年   10712篇
  2001年   1546篇
  2000年   1185篇
  1999年   1643篇
  1998年   2345篇
  1997年   2032篇
  1996年   1712篇
  1995年   1588篇
  1994年   1434篇
  1993年   1365篇
  1992年   1089篇
  1991年   999篇
  1990年   880篇
  1989年   864篇
  1988年   890篇
  1987年   750篇
  1986年   867篇
  1985年   944篇
  1984年   1234篇
  1983年   1196篇
  1982年   1656篇
  1981年   1526篇
  1980年   1424篇
  1979年   815篇
  1978年   927篇
  1977年   813篇
  1976年   719篇
  1975年   578篇
  1974年   607篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
71.
72.
73.
74.
75.
Summary An infant girl is described who had cor triatriatum and partial anomalous pulmonary venous connection of the left pulmonary veins to the coronary sinus, the first report of this combination of lesions. The infant also had a Dandy-Walker malformation and multiple facial and intrathoracic hemangiomas. The cardiac diagnosis was made by two-dimensional echocardiography. Cardiac catheterization and angiography confirmed the findings and also demonstrated a persistent left superior vena cava draining to the coronary sinus. The infant underwent successful surgical repair. Partial anomalous pulmonary venous connection and left superior vena cava not infrequently are associated with cor triatriatum. Although two-dimensional echocardiography is sensitive for the detection of cor triatriatum, preoperative cardiac catheterization is necessary to identify unequivocally systemic and pulmonary venous connections.  相似文献   
76.
Unfractionated cytokines have been shown to induce in vitro proliferation of neonatal rat Schwann cells but the nature of the mitogen(s) is not known. A mixture of rabbit antibodies specific for recombinant interleukin-1α (IL-1α) and interleukin-1β (IL-1β) inhibited Schwann cell proliferation induced by unfractionated human cytokines whereas antibodies to interleukin-2 (IL-2) and control IgG did not. However, purified human IL-1 and recombinant human IL-1α or β did not induce Schwann cell proliferation on their own.  相似文献   
77.
78.
Polycystin-1, the product of the PKD1 gene, is a membrane-bound multidomain protein with a unique structure and a molecular weight of approximately 460 kD. The purpose of this study is to investigate the binding of the cystein-flanked leucine-rich repeats (LRR) of polycystin-1 to extracellular matrix (ECM) components. These interactions may play a role in normal renal development as well as the pathogenesis of autosomal-dominant polycystic kidney disease (ADPKD). In vitro assays were used to assess the binding of a fusion protein containing the LRR of polycystin-1 and that of affinity purified polycystin-1 to a number of ECM components. The results showed that the LRR modulate the binding of polycystin-1 to collagen I, fibronectin, laminin, and cyst fluid-derived laminin fragments. The addition of the LRR fusion protein to cells in culture resulted in a significant dose-dependent reduction in the rate of proliferation. Cyst fluid-derived laminin fragments had a stimulatory effect on cell proliferation, which was reversed by the LRR fusion protein. These results suggest that the LRR of polycystin-1 act as mediators of the polycystin-1 interaction with the ECM. The observed suppression effect of the LRR on cell proliferation suggests a functional role of the LRR-mediated polycystin-1 involvement in cell-matrix and cell-cell interactions. These interactions may result in the enhanced cell proliferation that is a characteristic feature of ADPKD.  相似文献   
79.
Summary Cytosine arabinsodie (ara-C) and etoposide (VP-16) display synergy in the laboratory. Twenty-six patients participated in a phase I study of high-dose ara-C in combination with VP-16. The dose of VP-16 was held constant at 50 mg/m2 as an intermittent infusion over 33 h; escalating doses of ara-C were given as infusions during hours 9–12 and 21–24. Myelosuppression was the dose-limiting toxicity and occurred with doses considerably less than those expected from studies of the two drugs as single agents. The suggested initial doses for phase II trials with this schedule are 750 mg/m2×2 doses of ara-C and 50 mg/m2 of VP-16. Nonhematologic toxicity was minimal; therefore, further dose escalation is feasible in patients in whom myelosuppression is acceptable.Supported in part by grants from the National Cancer Institute (CA-12197 and CA-09422) and the American Cancer Society CF-85-182  相似文献   
80.
THE BASIC SCIENCE OF PSYCHOLOGY HAS IDENTIFIED specific ingrained responses that are fundamental elements of human nature, underpin common influence strategies and may apply in medical settings. People feel a sense of obligation to repay a perceived debt. A request becomes more attractive when preceded by a marginally worse request. The drive to act consistently will persist even if demands escalate. Peer pressure is intense when people face uncertainty. The image of the requester influences the attractiveness of a request. Authorities have power beyond their expertise. Opportunities appear more valuable when they appear less available. These 7 responses were discovered decades ago in psychology research and seem intuitively understood in the business world, but they are rarely discussed in medical texts. An awareness of these principles can provide a framework for physicians to help patients change their behaviour and to understand how others in society sometime alter patients' choices.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号